HRSA’s supposed lack of authority to enforce its 340B guidance is central to the recent debate over the contract pharmacy program. With a new administration, we should expect to see stronger enforcement from HRSA, as well as the possibility of new guidance.
The Autonomous Pharmacy is a bold new vision for the future of medication management for health systems, leveraging automation, intelligence, and technology-enabled services to improve the safety and accuracy of every aspect of the drug delivery process. The goal of this industry movement is to achieve zero-error medication management, while freeing pharmacists to practice at the top of their license.
COVID-19 vaccines are now being distributed across the USA and administered to an expanding universe of patient populations. It’s clear that retail pharmacies will play a critical role in the vaccination of the general public in the coming months.
Imagine if Amazon lost one out of every 10 packages. Or the airlines lost 10% of passenger bags. As consumers this would be unacceptable. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products?
The Pharmacy of the Future will be defined by superior medication inventory optimization across the continuum of care. Through digital automation, visibility, intelligence, and actionable insights, the hospital pharmacy will improve business and patient satisfaction.
While 340B providers welcomed the December 30 advisory opinion from outgoing Health and Human Services Department (HHS) General Counsel Robert Charrow and have reason to be excited about the incoming Biden administration and the Democratic takeover of the Senate, it will likely take some time for the legal process to play out.
Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
The Democrats' recent sweep of the United States Senate Georgia runoff elections means the Democrats will control both chambers of Congress as well as the White House for the first time since 2010. A number of Democratic leaders in Congress consider this as a clear mandate to aggressively pursue their agenda and enact “bold change.”
As the economic slowdown and rising unemployment levels have disproportionately impacted the underprivileged and uninsured—many that are served by 340B covered entities—the financial pressures are mounting for providers.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.